Novo Nordisk CEO testifies before Senate on weight loss drug prices

Novo Nordisk CEO testifies before Senate on weight loss drug prices


Share

CNBC’s Angelica Peebles reports on Novo Nordisk’s testimony before 
the Senate Health, Education, Labor, and Pensions Committee.

01:54

Tue, Sep 24 202411:20 AM EDT

.



Source link

More From Author

Blackstone and Vista Equity Partners to acquire software maker Smartsheet for .4 billion

Blackstone and Vista Equity Partners to acquire software maker Smartsheet for $8.4 billion

Mueller investigator says Russia interfered in 2016 — and in the 2024 election too

Mueller investigator says Russia interfered in 2016 — and in the 2024 election too

Leave a Reply

Your email address will not be published. Required fields are marked *